Sonny Hsiao
Founder & Chief Executive Officer Acepodia Biotech
Seminars
Tuesday 4th November 2025
Showcasing Development & Application of Antibody-Dual-Drugs Conjugation (AD2C™) platform
2:30 pm
- Introducing the advantages and differentiation of AD2CTM platform for ADC development
- Applying AD2CTM platform in development of anti-GPC3 ADCs with dual payloads for hepatocellular carcinoma treatment
